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Tick-borne encephalitis virus (TBEV) is a tick-transmitted arbovirus that causes serious
diseases in humans in Europe and Northern Asia. About 6000–10,000 cases are
registered annually, and one-third of them lead to sequela with different degrees of
severity. Two TBEV strains (Absettarov and EK-328) similar in virulence rate in laboratory
mice were used to study pathogenesis and immune response upon lethal infection
in mice. The strains differed in the dynamics of appearance of virus, IFNs and other
cytokines in blood of mice, and ability to induce a cytokine storm in the terminal stages of
disease and a non-sterile immunity. Moreover, the TBEV strains differed in characteristics
of their interactions with DCs: level of reproduction in these cells, virus dose triggering
IFN-α production, and impact on DCs’ maturation. Infection of DCs with Absettarov
strain led to IFN-α induction only at high multiplicity of infection (MOI), and an increased
amount of the mature DCs with high adhesion activity and low-level of MHCII positive
cells. While reproduction of the EK-328 strain in DCs was less efficient, a low dose of
the virus induced IFN-α production and stimulated maturation of DCs with relatively low
adhesive capacity, but with the high percentage of cells expressing MHCII molecules.
Thus, the studied strains differed significantly in the impact on DCs’ maturation and
antigen presentation to CD4+ lymphocytes. Injection of low (103 PFU) and high (106 PFU)
doses of both TBEV strains caused a lethal infection in mice. At the same time, the dose
of the virus in the inoculum, regardless of the strain properties, affected the following
virulence characteristics: the time of virus appearance in brain (day 4–5 vs. day 1 p.i.),
time of IFN-α appearance in blood (10 h vs. 5 h p.i.), concentration of IFN-α in blood,
and induction of IFN-α during infection of DCs. Therefore, virulent TBEV strains during
lethal infection can interact differently with the host immune system, and the infectious
dose has an impact on both: virus spread in the infected organism and immune response
activation.
Keywords: tick-borne encephalitis virus, pathogenesis, dendritic cells, cytokines, interferon, immune response,
flavivirus, non-sterile immunity
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INTRODUCTION
Tick-borne encephalitis (TBE) is one of the most serious
arboviral human diseases in Europe and Northern Asia affecting
the CNS. TBE is caused by a tick-transmitted mammalian
Flavivirus, TBEV. Human infection usually occurs after a tick bite
and results in cases with different outcomes, from asymptomatic
infection to severe meningitis, meningoencephalitis, and
encephalitis that can be fatal or can transform into a chronic
disease.
TBE pathogenesis has been studied in detail on materials
from patients with different forms of disease (Shapoval, 1961;
Erman et al., 2001; Kaiser, 2008). Recently, activation of the
immune system and brain inflammatory reaction in TBE patients
has been estimated by measuring the level of the corresponding
cytokines, enzymes, and other factors in blood and cerebrospinal
fluid (Timofeev et al., 2002; Atrasheuskaya et al., 2003; Palus
et al., 2015; Grygorczuk et al., 2016). Nevertheless, experiments in
laboratory animals are required for evaluation of the pathogenic
potential of the virus. Animal models allow reducing the
influence of genetic diversity and immune status of test subjects
and infectious doses of the virus and facilitate the ability to
follow the initial stages of virus reproduction and activation of
the immune responses.
There is a number of investigations that have studied TBEV
pathogenesis in a laboratory mouse model using strains isolated
from patients and from field-collected ticks, wild animals, and
birds. The dynamics of virus distribution and reproduction in
different organs, activation of the immune system, and virus
interaction with cells of the immune system has been studied
(Shubladze, 1939; Albrecht, 1968; Il’enko et al., 1974; Hayasaka
et al., 2009; Ruzek et al., 2009; Tigabu et al., 2010; Tun et al., 2014).
Dendritic cells (DCs) play a special role in the initial stages
of infection. Virus replication in DCs and virus manipulation
of their maturation have been demonstrated for mosquito-
borne flaviviruses: Dengue virus (Chase et al., 2011; Webster
et al., 2016), Japanese encephalitis virus (JEV; Cao et al., 2011),
West Nile virus (WNV; Rawle et al., 2015), and Yellow fever
virus (YFV; Barba-Spaeth et al., 2005). There are some data
for naturally attenuated tick-borne flavivirus Langat (LGTV;
Robertson et al., 2014), but TBEV infection of DCs remains
poorly characterized.
Many studies have been focused on comparison of highly
virulent and attenuated TBEV variants in order to establish the
features of the immune system activation in infected animals with
different forms of disease, and to identify factors determining the
pathogenetic characteristics of the virus. Authors used different
approaches to evaluate the virulence for laboratory mice and to
choose the appropriate infectious dose for compared viral strains.
Usually, virus doses were based on plaque-forming units (PFU),
sometimes on the amount of lethal doses (LD50) in the inoculum.
The compared strains probably could vary significantly in the
ratio of “virulent” virions capable of causing the disease in
laboratory animals and “non-virulent” virions that could form
plaques in vitro but were incapable of causing an acute infection
in vivo, but still could influence the immune response. In light of
this, the accuracy of the virus dose in the inocula comes under
question. It is important to distinguish the differences related
to the virus features, infectious doses, or composition of the
virus population. The complexity of this problem determines
the difficulty in creating a general picture of pathogenesis and
immunogenesis during the experimental TBE. This information
is important to understand the way of TBEV manipulations of
mammalian immune response and can be crucial for antiviral
drugs design.
In the present study we compared the pathogenesis and
immune response after lethal infection caused by two TBEV
strains similar in virulence rate in laboratory mice. It was
shown that several characteristics were determined by the virus
infectious dose. The virulent TBEV strains were found to vary




A pig embryo kidney (PEK) cell line was maintained in medium
199 (PIPVE, Russia) supplemented with 5% fetal bovine serum
(FBS) (Gibco, Invitrogen, South America) at 37◦C.
Murine DCs (bmDCs) were derived from bone marrow
progenitor cells of BALB/c mice (female) after culturing in RPMI
1640 (PIPVE, Russia) supplemented with 10% heat-inactivated
FBS, recombinant mouse IL-4, and GM-CSF (Invitrogen).
Cytokines (20 ng/ml) were added on the days 1 and 3. After 7 days
in culture, bmDCs were infected with viruses. DCs morphology
was assessed by light microscopy.
Viruses
TBEV strain EK-328 (GenBank ID DQ486861, Romanova et al.,
2007) was isolated from Ixodes persulcatus in Estonia in 1972,
and underwent eight passages in mouse brain with or without an
additional passage in PEK cells.
TBEV strain Absettarov was isolated from the blood of a
patient with TBE in the Leningrad region in 1951. This strain
underwent about 20 passages in mouse brain with or without
one passage in PEK cells. The full genome sequence of this strain
(GenBank ID KU885457), except for the first 16 nucleotides
(nt) of 5′-UTR and the last 60 nt of 3′-UTR, differed from the
sequence of the strain called Absettarov (GenBank ID KJ000002)
in 73 nt, of which 20 led to amino acid substitutions in all viral
proteins except E and C, as well as to deletion of 272 nt in 3′-UTR.
Reference vaccine strain Sabin 1 of poliovirus type 1 (GenBank
ID V01150) originated from NIBSC (UK).
Viruses were stored as aliquots of 10% infected mouse brain
suspension or infected PEK cell culture supernate (CS) at−70◦C.
Flow-Cytometry Analysis
The fractions of DCs expressing different surface cell
determinants (CDs) were measured by flow cytometry. At
72 h after TBEV infection, DCs were harvested, washed, and
suspended in RPMI-1640 (PIPVE, Russia) with 1% BSA.
Cell suspensions were labeled with the following anti-mouse
antibodies (Abs): CD38-FITC (clone 90), CD83-FITC (clone
Michel-17), CD86-PE (GL-1), CD80-PE (clone 16-10A1),
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CD11c-FITC (clone N418), MHCII (clone 14-4-4S) (BD
Biosciences, USA), CD34-PE (clone MEC 14.7, Invitrogen,
USA), and CD40-FITS (clone 3/23, BioLegend, USA) for 30 min
at room temperature, washed, and fixed in 2% paraformaldehyde
in PBS (Sigma-Aldrich). The percentage of cells expressing
different CD molecules was analyzed using a FC-500 two-laser
flow cytometer (Beckman-Coulter, USA). DCs incubated with
20 ng/ml TNF-α served as the positive control and bmDCs
incubated with CS of uninfected PEK cells served as a negative
control. The mean and standard deviation (s.d.) values for the
experimental data were calculated. Mann-Whitney U-test was
used to compare the percentage of infected cells vs. negative and
positive controls.
Immunofluorescent Assay
DCs were stained with human serum obtained after
immunization with inactivated TBE vaccine and labeled
with FITC-conjugated anti-human IgG (Sigma-Aldrich). Stained
cells, containing viral proteins, were counted using Nikon Eclipse
Ti-U microscope equipped with fluorescent filters.
Plaque Assay and 50% Plaque Reduction
Neutralization Test
The plaque assay procedure was described previously (Pripuzova
et al., 2009). Briefly, PEK cells seeded in 6-well plates (Corning)
were incubated with 10-fold dilutions of virus samples for 1 h.
Then, each well was overlaid with 5 ml of 1% agar (Difco) on
Earle’s balanced salt solution (PIPVE, Russia) containing 7.5%
FBS and 0.015% neutral red. After 6–14 days of incubation at
37◦C plaques were counted and virus titers were calculated as the
log10PFU per ml.
The 50% plaque reduction neutralization test (PRNT) was
performed as described in Pripuzova et al. (2013): serial 2-
fold dilutions of serum were prepared in 0.2 ml volumes.
Virus diluted to contain approximately 30–40 PFUs was then
added at a volume of 0.2 ml to each serum dilution, and
mixtures were incubated at 37◦C for 1 h. Then, the virus–serum
mixtures were inoculated into wells with PEK cell monolayer
in a volume of 0.4 ml, and the cells were incubated for 1
h for adsorption of non-neutralized virus. After incubation,
each well was overlaid with agar (as described above) and
incubated at 37◦C for 5–6 days. Neutralizing antibody (Ab) titers
were expressed as the highest serum dilution producing a 50%
reduction of plaque count in comparison with the control, in
which the test dose of the virus was incubated in the presence
of serum from a non-infected mouse instead of examined
serum.
Virulence in Mice
All experiments were carried out in 10–12-week-old female
BALB/cmice (FSBI Scientific Center of Biomedical Technologies,
Stolbovaya branch, Russia). The mice were maintained according
to the international guidelines for animal husbandry, including
the recommendations of Bankowski and Howard-Jones (1985)
and the FELASA Working Group Report (1996–1997). The
protocol was approved by the Chumakov IPVE ethics committee.
TBEV strains were tested for either neurovirulence after
intracerebral (IC) inoculation (30 µl) or for neuroinvasiveness
after intraperitoneal (IP) inoculation (300 µl) or subcutaneous
(SC) inoculation (100 µl; into the upper thigh). The mice
were observed for 21 days after inoculation, clinical symptoms
and deaths were recorded. LD50 was calculated according to
the Kerber method (Lorenz and Bogel, 1973). The data were
statistically processed using the Student test or Wilcoxon two-
sample test.
Detection of Antiviral Abs in the Mouse
Sera by ELISA
For antiviral Abs titration, ELISA was performed using the
standard technique (Pripuzova et al., 2013) by the following
scheme: 1st layer—non-inactivated virus antigen (Ag), 2nd
layer—2-fold dilutions of the analyzed serum, 3rd layer—anti-
mouse Abs (Anti-Mouse IgG IgA IgM (H+L) HRP-conjugated,
Sigma-Aldrich).
Ag was prepared from concentrated CS of infected PEK cells
using ultracentrifugation. The negative control Ag was prepared
from CS of non-infected cells using the same method. Viral
and negative control Ags were normalized by total protein
content. The final Ab titer was calculated as the last serum
dilution that gave an optical signal with the viral Ag 2-fold
higher than the control Ag. All sera were tested in at least two
replicates.
ELISA for Cytokine Analysis
The concentrations of cytokines in mouse sera were detected
by commercial ELISA kits (Genzyme and R&D Systems, Great
Britain; Bio Source int., Belgium; PBL Biomedical Laboratories,
USA) according to the manufacturer’s instructions. The results
were presented in pg/ml. Murine IFN-α in DCs supernate was
measured by VeriKine Mouse IFN alpha ELISA Kit (Thermo
Fisher Scientific Inc., USA). The data were statistically processed
using the Student test.
Real-Time PCR
Viral RNA was extracted from 10% brain or spleen suspensions
using TRI Reagent LS (Sigma Aldrich, USA) according to the
manufacturer’s instructions. Sabin type 1 poliovirus was used
as an internal control and was added to the samples prior
to RNA extraction. Reverse transcription was carried out with
M-MLV reverse transcriptase (Promega, USA) according to the
manufacturer’s protocol with specific primers. Oligonucleotides
for the Absettarov strain were used for reverse transcription
and real-time PCR, as described previously (Schweiger and
Cassinotti, 2003), and 3′-UTR was used as a target for real-time
PCR. The oligonucleotides for the EK-328 strain and poliovirus
were used for reverse transcription and real-time PCR, as
described previously (Romanova et al., 2007), and NS5 was used
as the target gene to perform real-time PCR for the EK-328 strain.
Real-time PCRwas carried out using a RealTime-PCR kit (Syntol,
Russia). A standard curves were created using serial dilutions of
TBEV RNA purified from CS of PEK cells by centrifugation in
sucrose gradient as described previously (Gmyl et al., 2003).
Frontiers in Microbiology | www.frontiersin.org 3 January 2017 | Volume 7 | Article 2172
Shevtsova et al. Experimental Tick-Borne Encephalitis
RESULTS
Virulence Characteristics of Studied TBEV
Strains in Mice
For the present work, two TBEV strains, Absettarov and EK-
328, with a high virulence rate in laboratory mice were selected
(Kozlovskaya et al., 2010). The virus dose (LD50), expressed in
PFU causing death of 50% of animals for both strains, slightly
varied in different experiments even though the animals were
from the same provider. In order to compare virulence of the
investigated TBEV strains, data about virus titers in cell culture
and in experiments in mice from several years were collected,
and the variance between virulence rates in different experiments
was evaluated. For each strain, data for virus obtained after
reproduction in mouse brains (i.e., taken for the experiments
in the form of brain suspension of infected mice) and after
reproduction in cell culture (i.e., taken for the experiments in the
form of CS from infected PEK cells) were analyzed.
For the Absettarov strain, the virus obtained after
reproduction in mouse brain was more virulent than the
one obtained after replication in PEK cells. IP injection of
the virus from CS caused the death of 50% of animals with
an infectious dose of 2.8 log10PFU, while the infectious dose
for the virus obtained from the brain was 0.6 log10PFU (P <
0.05; Table 1, index c). The average life expectancies (ALE) of
animals after IP infection with CS and brain viruses were similar;
however, for animals SC infected with CS virus, the ALE was
statistically higher (Table 1, index f).
For the EK-328 strain, a higher virulence rate of brain virus in
comparison with CS virus was observed after IP inoculation (P<
0.05, Table 1, index d), but not after SC injection. A significant
increase in ALE could not be established.
According to average calculations, a dependence of the virus
virulence rate on the inoculation route for both strains could
be observed. It decreased in series: IC to IP to SC injections.
However, statistically significant differences in virus virulence
rates were established only for IC inoculation of the Absettarov
strain in comparison with IP inoculation (Table 1, index a) and
SC inoculation (Table 1, index b). Noteworthy, the Absettarov
strain population contained virions that could cause infection in
mice after IC injection, but were unable to form a plaque in PEK
cells (1LD50 corresponded with 0.1 PFU).
The average virulence rates were similar for both strains, but
ALE for the brain variant of the EK-328 strain was significantly
higher (P < 0.01) than the one for the Absettarov strain upon IP
and SC inoculation routes (Table 1, indexes e and g).
Characteristics of the Mice Infection
First, brain grown virus stocks of both investigated viruses were
compared upon IP injection, when the two strains demonstrated
the most similar characteristics. The infection parameters were
analyzed after IP inoculation of 103 PFU of both viruses. Daily
three of infected mice were autopsied without perfusion, but
after total bleeding, and samples of brain, spleen, and inguinal
and popliteal lymph nodes were collected. Titers of infectious
virus in the samples were measured by plaque assay in PEK cells.
In previous experiments, we have found that the titers of the
infectious virus in blood clots are similar or higher than in sera
(Pripuzova et al., 2009). Therefore, to estimate the viremia in this
experiment, we utilized 10% blood clot suspensions. Serum pools
from three animals were used to determine the levels of selected
cytokines and Abs.
In this experiment, symptoms of the disease developed on
days 6–7 after IP infection with the Absettarov strain, and by
day 9, all animals died. We observed two waves of viremia
(Figure 1A). Infectious virus titers in the peripheral lymph nodes
correlated with the highest virus titers in blood of infected
animals and were detected on days 3 and 6 post-infection (p.i.)
(Figure 1A). The virus appeared on day 2 p.i. in spleen. In brain,
virus appeared on day 5 p.i., which coincided with the second
peak of viremia.
After IP infection of 103 PFU of the EK-328 strain, acute
infection with two-wave viremia was also observed, but the first
wave was higher (Figure 1B). Infectious virus was detected in the
peripheral lymph nodes on day 7 p.i., but in spleen the virus
was observed from the first day (Figure 1B). Infectious virus
appeared in brain of mice infected with the EK-328 strain 1 day
earlier than in Absettarov-infected animals. The animals got sick
on days 7–9 p.i. and died within 2–3 days after the disease onset.
Thus, the virus was detected in brain 4–5 days p.i., and two-
wave viremia was demonstrated for both TBEV strains; however,
the viruses differed in the relation of the peaks.
The Selected Cytokines Dynamics in
Mouse Serum
Pooled sera from three mice were used to evaluate immune
response activation after IP inoculation of brain grown stocks of
the TBEV strains in a dose of 103 PFU. The virus distribution
in organs of these animals was described above. The levels
of selected cytokines were measured in serum using ELISA
and compared with the cytokine levels in the sera of mice IP
inoculated with brain suspension from a non-infected mouse in
the corresponding dilution (Table 2a).
Starting from the first day of severe infection caused by 103
PFU Absettarov strain, no TNF-α or IL-2 were detected in sera
of infected mice (Table 2a). IL-10 production increased on the
first day p.i. and decreased by day 4. IL-12 appeared on day 2,
IFN-γ on days 4–5, and IL-6 on day 4. On day 7 p.i., when the
first symptoms of the disease appeared, an increase in IFN-γ, IL-
6, IL-10, and TNF-α was found, which could be considered as a
cytokine storm.
In the infection caused by 103 PFU EK-328 strain, IL-10 was
not detected over the first 6 days p.i. (Table 2a). IFN-γ and IL-
6 were detected by 1 day earlier than in Absettarov-infected
mice. We also observed an increase in IL-12, IFN-γ, and TNF-
α concentration on days 4–5 p.i. On day 7, an increase in IL-10
and IL-6 production was observed, but it was less pronounced
than in Absettarov-infected mice.
The obtained data indicated that during severe form of
experimental TBE infection, days 3–4 p.i., when INF-γ and IL-
6 appeared in the bloodstream, were a critical moment for the
development of the specific immune response. IFN-γ restores
the balance between Th1 and Th2 lymphocytes and suppresses
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TABLE 1 | Virulence rates of the Absettarov and EK-328 strains (represented as log10PFU) in BALB/c mice upon different routes of injection.
Strain LD50 (log10PFU, M ± S) Average life expectancy (days)
Inoculation of 103 PFU
IC IP SC IP SC
Absettarov Brain −1.2 ± 1.3 (3) a,b 0.6 ± 0.4 (27) a, c 1.4 ± 1.4 (8) b 10.0 ± 0.2 [63] e 10.0 ± 0.2 [29] f, g
CS n/a 2.8 ± 0.2 (2) c 2.4 ± 0.5 (2) 10.5 ± 0.7 [4] 12.4 ± 0.3 [10] f
EK-328 Brain 0.04 ± 0.3 (2) 0.7 ± 0.6 (4) d 1.3 ± 0.0 (6) 12.1 ± 0.7 [34] e 13.4 ± 0.7 [13] g
CS n/a 1.7 ± 0.3 (5) d 1.6 ± 0.2 (3) 10.1 ± 0.7 [8] 14.0 ± 1.9 [4]
Mice were infected with the brain grown virus stocks.
M–geometric mean of titers in several experiments.
S–standard error.
()–number of experiments.





IP – intraperitoneal injection.
SC – subcutaneous injection.
a–d–values indicated pairwise are significantly different according to Student’s t-test (P < 0.05).
e–g–values indicated pairwise are significantly different according to Wilcoxon two-sample test (P < 0.01).
FIGURE 1 | The infectious virus detection in blood, brain, spleen, and lymph nodes of infected mice (pool from three animals; inoculated virus in the
form of brain suspension) at different time points post infection: the animals IP infected with 103 PFU of TBEV Absettarov strain (A), with 103 PFU the EK-328
strain (B). Virus yields in 10% tissue suspensions were determined by plaque assay in PEK cells.
IL-10 production (Hu et al., 2006; Cope et al., 2011), whereas
IL-6 increases proliferation and differentiation of B-lymphocytes,
which results in specific Abs production.
In additional experiment four mice were infected with high
(106 PFU) doses of both strains. On day 6 p.i., IFN-γ and IL-6
were assayed in individual serum samples from the sick animals.
As shown in Table 2b, sera of all infected animals contained high
concentrations of both cytokines. The IFN-γ/IL-6 ratios were 0.4
and 0.5 for the Absettarov and EK-328 strains, respectively, vs. 1.5
in control samples. Thus, Th2 cells might play the leading roles
in Th1/Th2 immune balance in pathogenesis of TBE caused by
either of these two strains.
Moreover, we could observe a cytokine storm at the terminal
stage of infection. These highly virulent TBEV strains differed
in the dynamics of the appearance of cytokines in the serum of
infected mice and a cytokine storm.
The Dynamics of the Appearance of
Antiviral Abs in Mouse Serum after IP
Inoculation
Sera from infected mice, obtained during the experiment
described above, were assayed in ELISA for the presence of
antiviral Abs. As shown in Table 3, Abs appeared on day 4 p.i.
The level of antiviral Abs and their dynamics were similar for
both studied TBEV strains.
The same sera pools from infected animals taken on day 6
p.i. (Figure 1) were analyzed in the PRNT. The titers of virus-
neutralizing Abs in mouse blood were similar for both viruses
(Table 4). In addition to neutralizing Abs, 2.1 log10PFU/ml of
infectious virus was detected in the sera of Absettarov-infected
mice. Titers of the infectious virus were very low in blood
of EK-328-infected mice. Therefore, the non-sterile immunity
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TABLE 2a | The dynamics of the selected cytokines appearance in sera of infected mice.
Cytokines (pg/ml) Day of infection
1 2 3 4 5 6 7
Abset EK Abset EK Abset EK Abset EK Abset EK Abset EK Abset EK
TNF-α – – – – – – – – – 107 – – 315 ± 43 n/a
IL-10 101 ± 34 – 9 ± 7 – 14 ± 7 – – – – – – – 45 ± 14* 33 ± 1*
IFN-γ – – – – – 30 ± 2 27 ± 5 49 ± 11 39 ± 10 – – – 284 ± 36 n/a
IL-12 – – 328 ± 17 – – – – 292 ± 31 n/a n/a n/a n/a n/a n/a
IL-6 – – – – – 74 ± 6 69 ± 9 – – – – – 640 ± 85 113 ± 9
IL-2 – – – – – – – – – – – – – n/a
Animals were IP infected with 103 PFU of the brain grown stocks of the Absettarov and EK-328 strains.
n/a–not analyzed.
“–”– concentration of cytokine lower than in control serum, which was obtained from animals after injection of brain suspension from non-infected animals with subsequent dilution
(pg/ml): TNF-α, 23 ± 5; IL-10, 5 ± 2; IFN-γ , 25 ± 2; IL-12, 131 ± 56; IL-6, 16 ± 1; IL-2, 10 ± 2.
*Indicates the data for sick animals; for mice without clinical manifestation, the concentration of the interleukin on the indicated day was lower than in the control.
TABLE 2b | Concentration of cytokines in sera of infected mice (6 d p.i.).
Cytokine (pg/ml) Absettarov EK-328 Control
IFN-γ 38 ± 7 48 ± 3 12 ± 3
IL-6 108 ± 68 96 ± 35 8 ± 1
INF-γ/IL-6 0.35 0.5 1.5
Animals were IP infected with 106 PFU of the brain grown stocks of the Absettarov and
EK-328 strains.
TABLE 3 | Titers of antiviral Abs in the sera of infected animals in ELISA.
Strain Day of infection
1 2 3 4 5 6 7
Absettarov 0 0 0 1:160 1:160 1:320 1:320
EK-328 0 0 0 1:160 1:160 1:160 1:320
Mice were IP infected with 103 PFU of the brain grown stocks of the Absettarov and EK-
328 strains.
Sera samples were polled from three mice.
phenomenon was observed on the second wave of viremia,
when neutralizing Abs and infectious virions co-circulate in
bloodstream. Moreover, the studied strains differed in this
property.
In additional experiments, we examined the ability of the
serum Abs to neutralize the virus used for inoculation and the
virus from mouse brains taken during infection. We investigated
the sera of mice taken on day 6 after IP injection of 103
PFU of the Absettarov and EK-328 strains in the PRNT.
Brain samples were collected simultaneously with the sera from
the same animals. For EK-328-infected animals, the titer of
Abs neutralizing the virus used for inoculation was higher
(P < 0.05) than the ones neutralizing the virus from the
brain of this mouse (Table 4), while Abs in the sera of mice
infected with the Absettarov strain efficiently neutralized both
viruses.
TABLE 4 | Geometric mean titers (GMTs, log10) of neutralizing Abs in mice
sera on the 6th day after TBEV inoculation.
Sera used in
neutralization test




brain of infected mouse
ABSETTAROV STRAIN
Serum of mouse infected
with strain Absettarov
2.2 ± 0.1 2.2 ± 0.2
EK-328 STRAIN
Serum of mouse infected
with strain EK-328
2.4 ± 0.1 1.6 ± 0.2
Mice were IP infected with 103 PFU of the brain grown stocks of the EK-328 and
Absettarov strains.
Serum and brain were taken from infected animals on the 6 d p.i.
The Detailed Characteristics of the First
Stages of Infection
The main events associated with innate immunity activation
and, consequently, with specificity of infectious processes occur
during the first stages of infection. In further investigation, we
used CS from infected PEK cells to prevent the potential impact
of even trace amount of brain suspension in the inoculum on the
results. The control group comprised mice injected with CS from
non-infected PEK cells.
We evaluated the first stages of virus infection after IP
inoculation of 103 and 106 PFU of the cell culture grown stocks
of the investigated strains. At different time points, samples of
blood, brain, and spleen were taken from 3 to 5 mice infected
with each virus. The presence of viral RNA was assayed by real-
time PCR in 10% spleen and brain suspension separately for
each animal. The 10% blood clot suspensions were used for virus
titration by plaque assay. The level of cytokines was measured in
the sera of infected mice by ELISA.
The dynamics of virus appearance in blood during the first
stage of infection was similar for both viruses. The infectious
virus was detected 5 h p.i. for both infectious doses (Table 5a);
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however, the virus titers were higher in blood of mice infected
with 106 PFU of viruses. Assuming that TBEV reproduction cycle
is longer than 12 h, we could estimate that the infectious virus
detected 5 h p.i. is the inoculated one.
Twenty-eight hours p.i. of the high dose (106 PFU), real-
time PCR and plaque assay revealed infectious virus in brains
of two out of three EK-328-infected mice and three out of three
Absettarov-infected mice. The infectious virus titers were very
low and similar for both investigated viruses. After inoculation
of the low virus dose (103 PFU), the infectious virus was not
detected in the mouse brain for either studied strains (Table 5b).
The level of viral RNA in spleen after the low dose infection
was below the test sensitivity threshold for both studied viruses
(Table 5c).
Thus, for both TBEV strains the virus titers in spleen and brain
varied with the infectious dose. After inoculation of the high dose,
the infectious virus appeared in spleen at 5 h p.i. and brain of
infected animal at 28 h p.i.
Activation of the Innate Immune Response
on the First Stages of Infection after IP
Inoculation of the TBEV Strains
The levels of TNF-α, IL-10, and IL-12 in blood serum of three
animals infected by IP inoculation of the cell culture grown stocks
of the Absettarov or EK-328 strains were measured by ELISA
(Table 6). We detected IL-10 and TNF-α in mouse sera 10 h
after Absettarov-strain infection. Later, concentration of TNF-α
TABLE 5 | The dynamics of virus appearance in blood, brain and spleen of mice during early stages of TBEV infection.
a. Viremia after IP inoculation of the Absettarov and EK-328 strains (plaque assay).
Strain Dose in inoculum (PFU) 5 h 10 h 28 h
Detection* GMT** Detection* GMT** Detection* GMT**
N = 3 (log10PFU/ml) N = 3 (log10PFU/ml) N = 5 (log10PFU/ml)
EK-328 103 1 1.4 0 – 3 1.9 ± 0.3
106 3 3.0 ± 0.6 3 1.9 ± 0.3 5 4.0 ± 0.2
Absettarov 103 3 1.6 ± 0.1 0 – 3 1.9 ± 0.0
106 3 3.7 ± 0.1 3 2.8 ± 0.2 5 3.8 ± 0.1
b. Geometric mean of viral titers and number of viral RNA copies in the brains of animals IP infected with the
Absettarov and EK-328 strains (28 h p.i.).
Strain Dose in inoculum (PFU) Plaque assay RT-PCR
Detection* GMT** Detection* GMT**
N = 3 (log10PFU/ml) N = 3 (log10RNAs/ml)
EK-328 103 0 – 0 –
106 2 0.8 ± 0.3 2 4.9 ± 0.2
Absettarov 103 0 – 0 –
106 3 0.8 ± 0.1 0 –
c. Viral RNA in spleens of infected mice (RT-PCR).
Strain Dose in inoculum (PFU) 5 h 10 h 28 h
Detection* GMT** Detection* GMT** Detection* GMT**
N = 3 (log10 RNAs/ml) N = 3 (log10 RNAs/ml) N = 3 (log10 RNAs/ml)
EK-328 103 0 – 0 – 0 –
106 3 4.0 ± 0.8 1 4.7 3 4.9 ± 0.2
Absettarov 103 0 – 0 – 0 –
106 3 5.4 ± 0.6 3 6.4 ± 0.2 3 4.2 ± 0.5
Mice were infected with cell culture grown virus stocks.
GMT–geometric mean titer.
N–total number of animals taken for experiment.
*–the number of animals in which blood (brain, spleen) the virus was detected.
**–in 10% tissue (brain, spleen) suspension.
“–” not detected.
Panel b–Real Time PCR sensitivity 1000 RNAs/sample.
Panel c–Real Time PCR sensitivity 3000 RNAs/sample.
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TABLE 6 | The dynamics of cytokines appearance in mouse sera during the early stages of TBEV infection.
Strain TNF-α (pg/ml) IL-10 (pg/ml) IL-12 (pg/ml)
5 h 10 h 18 h 24 h 10 h 18 h 24 h 10 h 24 h
Absettarov – 107 ± 19 – – 301 ± 10 20 ± 0 – – –
EK-328 – – 70 ± 9 – – 75 ± 5 – 352 ± 42 –
Control 23 ± 3 5 ± 2 131 ± 56
Mice were IP infected with 103 PFU of the cell culture grown stocks of the Absettarov and EK-328 strains.
“–”– concentration of cytokines lower or equal to the value in control sera obtained from animals after injection of CS of non-infected PEK cells.
decreased to the control level. In case of EK-328-infected mice,
TNF-α and IL-10 appeared in sera only in 18 h p.i, as the increase
in IL-12 production was detected in 10 h p.i.
TNF-α, a pro-inflammatory cytokine, indicates macrophage
and neutrophil activation. IL-10 is induced by TNF-α and,
in turn, down-regulates TNF-α synthesis (Platzer et al., 1995;
Brennan et al., 2008). Induction of IL-12 during the initial innate
immune responses elicits activation of natural killers, promotes
IFN-γ production, and increases CD4+ T-cell differentiation
(Tominaga et al., 2000). Activation of an adaptive immune
response that could be followed by the appearance of IL-6 and
IFN-γ in sera was detected by 1 day earlier in EK-328-infected
mice than in Absettarov-infected ones (Table 2a).
Thus, even though the TBEV strains did not differ by the
time of virus appearance in brain, spleen, and blood of infected
animals during the first day of infection, they showed significant
differences in the dynamics of pro-inflammatory cytokines
appearance in blood serum.
The Dynamics of the Interferon Synthesis
in Mouse Serum in the First Stages of
TBEV Infection
The rate of interferon synthesis during the first stages of infection
was assessed using ELISA. The concentration of cytokines in
blood sera were averaged over four animals.
The concentration of IFN-α in serum of infected mice was
dose-dependent for both viruses (Table 7a). After the low dose
of infection (103 PFU), we failed to detect this cytokine. After
infection with EK-328 strain in the high dose (106 PFU), IFN-
α was detected at 10 h p.i. After injection of 106 PFU of the
Absettarov strain, IFN-α appeared at 5 h p.i. followed by a 1.5-
fold increase at 10 h p.i. The Absettarov strain induced higher
titers of IFN-α production at all time-points.
The EK-328 and Absettarov strains induced production of
IFN-γ at 10 h after high-dose infection and reduction of IFN-
γ synthesis at 28 h p.i. (Table 7b). The concentration of IFN-γ
was lower in the sera of EK-328-infected mice than in the sera of
Absettarov-infected ones. The low dose of the Absettarov strain
induced the synthesis of IFN-γ only at 28 h p.i. and low dose of
EK-328 virus at 10 h p.i. This correlated with the detection of IL-
12 in the sera of animals infected with the low dose of EK-328.
Therefore, the level of IFN-γ production after low-dose infection
may depend on virus features.
TABLE 7 | The dynamics of interferons appearance in sera of TBEV
infected mice.
a. Concentration of IFN-α in the infected mice sera.
Strain Dose in inoculum (PFU) IFN-α (pg/ml)
5 h 10 h 28 h
EK-328 103 – – –
106 – 584 ± 10 194 ± 5
Absettarov 103 – – –
106 424 ± 90 711 ± 13 488 ± 10
Control 38 ± 8 11 ± 4 57 ± 14
b. Concentration of IFN-γ in the infected mice sera.
Strain Dose in inoculum IFN- γ (pg/ml)
5 h 10 h 28 h
EK-328 103 – 14 ± 4 –
106 – 45 ± 12 –
Absettarov 103 – – 19 ± 7
106 – 63 ± 3 –
Control – – 5 ± 0
Mice were infected with cell culture grown virus stocks.
“–”– concentration of cytokines lower or equal to the value in control sera obtained from
animals after injection of non-infected cells CS.
Interaction of TBEV Strains with Dendritic
Cells (DCs)
During the first stages of viral infection, DCs play an
important role in the initiation of the innate immune response
(Ag presentation and production of IFN-α). We compared
reproduction dynamics of the EK-328 and Absettarov strains and
evaluated their effects on DCs’ maturation and IFN-α synthesis.
Murine DCs obtained by adding IL-4 and GM-CSF to precursor
cells from the mouse bone marrow were used. On day 7 of
stimulation, DCs were infected with different doses of CS of PEK
cells infected with studied strains. The populations of DCs were
evaluated by the percentage of CD-marker positive cells using
flow cytometry. DCs incubated with CS from non-infected PEK
cells were used as a negative control. DCs incubated with TNF-α
were used as a positive control.
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In order to estimate the ability of the viruses to reproduce
in DCs, DCs were infected with high (10 PFU/cell), medium (1
PFU/cell), and low (0.1 PFU/cell) MOI of TBEV strains. Both
strains showed the level of reproduction in DCs of no more
5 log10 PFU/ml (data from four experiments). The absolute
values of virus titers changed from one experiment to another.
Nevertheless, all experiments had a similar profile. Figure 2
represents the dynamics of infectious virus accumulation in the
CS of DCs (mean data from four experiments).
Although, cells were washed from non-attached viruses after
adsorption, at the zero time point quite high titers of the virus
were detected that remained attached to the cell surface and did
not enter the cell. In all experiments, infection with high MOI of
both TBEV strains led to a slight variation in virus titers starting
from day 2 p.i. However, medium and low MOI provoked an
increase in virus titers in the CS. Titers in CS of Absettarov-
infected DCs were higher than the ones infected with the EK-328
strain at low and medium MOI at 72 h p.i. in all experiments
(statistical significance is confirmed by the sign test). The number
of infected DCs was estimated by immunofluorescent assay at 24
and 48 h p.i. using human polyclonal immune serum. At 24 h p.i.,
the number of infected cell was negligible even at high MOI. At
48 h p.i., the cells infected with high MOI of the Absettarov and
EK-328 strains constituted 0.5 and 1.7%, respectively.
Phenotyping showed that culturing of mouse bone marrow
precursor cells in the presence of IL-4 and GM-CSF (negative
control) increased percentage of DCs carrying immature cells
marker CD34, which indicated the functional immaturity of
non-infected DCs (Figure 3). Addition of TNF-α, a classical
inducer of maturation, to the cell culture (positive control) led
to a significant (p < 0.05) decrease of number of CD34+ DCs
in comparison with the negative control and an increase (p
< 0.05) in the content of cells expressing adhesion markers
CD38 and CD11c; co-stimulatory molecules CD80, CD86, and
CD40; molecules of Ag presentation MHCII; and terminal
differentiation CD83 (Figure 3).
Infection of immature DCs with the EK-328 strain was
followed by a statistically significant increase in the content of
cells carrying adhesion marker CD38; co-stimulatory molecules
CD80, CD86, and CD40; terminal differentiation CD83; and
molecules of Ag presentation MHCII in population compared to
the negative control. At the same time, the content of cells with
CD11c molecule remained at the negative control level, meaning
that cells that corresponded to mature DCs by their phenotypical
characteristics had low adhesive capacity (Figure 3).
Infection of immature DCs with the Absettarov strain led
to even more significant increase in the percentage of CD38 (p
< 0.05), CD40 (p < 0.05), CD83 (p < 0.05), and CD11c (p <
0.05) positive cells in comparison with the negative control, but
percentage of cells expressing MHCII molecule was considerably
lower that after infection with EK-328 strain. Moreover, the
Absettarov strain induced differentiation of the MHCII-positive
cells (compared to the control, p < 0.05). A peculiarity of the
Absettarov strain in comparison with the EK-328 strain was
its ability to stimulate expression of CD11c molecules on DC’s
surface (Figure 3).
In three experiments, the ability of the viruses to induce
IFN-α after DCs’ infection was estimated. The obtained data
showed significant variability in both: absolute levels of IFN-α
and number of samples with detectable levels of IFN-α (Table 8).
However, in DCs infected with the high MOI of the Absettarov
strain (10 PFU/cell) and the low MOI of the EK-328 strain (0.1
PFU/cell), IFN-α was detected within 5 h p.i. in all experiments.
In none of the experiments, IFN-α was detected within 5 h p.i. at
the low and mediumMOI of the Absettarov strain, and within 10
h p.i. at the high MOI of both strains.
The obtained data suggest that IFN-α induction during TBEV
infection of DCs occurs at the early stages of infection, and the
inducing dose depends on the TBEV strain.
DISCUSSION
A clarification of the factors determining the outcome of
the human contact with TBEV is a key for understanding
of the pathogenesis of infection, identification of virulence
determinants, and even evaluation of the epidemiological
situation in the natural foci (natural focus of an infectious disease
is a minimal territory of one or several landscapes, in which
the pathogen circulation maintains without importations for an
indefinitely long period of time, Kucheruk and Rosický, 1983).
A lot of factors can define the severity of the disease: genetic
predisposition and immune status of the mammalian host during
the tick bite, and some features of virus infection, including
infectious dose, properties of the infectious virus, time of the
FIGURE 2 | The dynamics of reproduction of the Absettarov and EK-328 strains in murine DCs (mean for four experiments) at different MOI [(A) 0.1, (B)
1, and (C) 10 PFU/cell]. Virus yields in culture supernatant were determined at different time points post infection by plaque assay in PEK cells.
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FIGURE 3 | Percentage of DCs with different CD markers at 72 h after infection with the Absettarov and EK-328 strains. DCs were infected with viruses at
MOI 10 PFU/cell. The fractions of DCs expressing different surface CDs were measured by flow cytometry.
TABLE 8 | IFN-α detection in supernates of infected DCs within 5 and 10 h
after TBEV infection at different MOI.
Strain MOI (PFU/cell) 5 h p.i. (Mean, pg/ml) 10 h p.i. (Mean, pg/ml)
Absettarov 0.1 0/3* 1/3 (13)
1 0/3 1/3 (47.7)
10 3/3 (20.4 ± 7.1) 0/3
EK-328 0.1 3/3 (18.6 ± 6.5) 2/3 (15.6 ± 0.6)
1 0/3 1/3 (15.4)
10 1/3 (17.9) 0/3
*Number of IFN-α ELISA positive samples (in numerator), number of experiments (in
enumerator).
tick feeding, location of the tick bite, composition and amount
of tick saliva, additional tick-borne pathogens, etc. Nevertheless,
the role of virus properties in the disease severity remains unclear.
Model experiments in inbred laboratory animals allow reducing
the influence of several from above-mentioned factors. However,
the first stage of a study should solve two problems: elucidate
and divide the effects, determined by the infectious dose and
virus features; and estimate the homogeneity of virus variants by
interaction with the host immune system.
In comparative experiments it can be difficult to equilibrate
different strains by infectious dose, because the virus populations
can vary in the percentage of the virions able to cause an acute
infection in mice. To avoid these difficulties two TBEV strains
were chosen for the present work: the Absettarov European
subtype strain and the EK-328 Siberian subtype strain, because
they demonstrated similar virulence rate in laboratory mice
(Kozlovskaya et al., 2010), i.e., PFU count sufficient to cause death
of 50% of animals.
The virus inoculation route is very important in the study
of the dynamics of the infectious process as well as for
characterization of the immune response activation. As it has
been demonstrated previously, in a short time after SC injection,
the virus can be found in fibroblasts and in the hypoderm near
the site of inoculation (Shi-Gie and Pogodina, 1964; Albrecht,
1968; Labuda et al., 1996). Virus particles captured by Langerhans
cells are transported to the lymph nodes (Labuda et al., 1996;
Banchereau and Steinman, 1998). After IP inoculation, the virus
can appear in the blood bypassing reproduction at the site of
injection. In this case, the first stages of the virus reproduction
mainly occur in the blood cells. Both virus administration routes
only partially simulate the process of natural infection after tick
bite. For our experiments, we chose IP injection.
Our data demonstrate that the characteristics of the infection
and activation of the immune response after IP inoculation
significantly depend on the virus dose in the inoculum. For
both TBEV strains, IP injection of low (103 PFU) and high (106
PFU) doses caused lethal infection. At the same time, the dose
of the virus in the inoculum, regardless of the strain properties,
affected the following characteristics of the infection: the time
of virus appearance in brain (day 4–5 vs. day 1 p.i.; Table 5b,
Figures 1A,B), time of IFN-α and IFN-γ appearance in blood
(10 vs. 5 h p.i.; Table 7a,b), concentration of IFN-α in blood
(Table 7a), and induction of IFN-α during infection of DCs
(Table 8).
Previous studies have shown virus appearance in the CNS
of mice 24 h after SC injection of a high dose of highly
virulent (Shubladze, 1939) and relatively low virulent (Hayasaka
et al., 2009) TBEV strains. In our work, the IP injection of
two highly virulent strains in the low dose led to a virus
appearance in the CNS on day 4–5 p.i., concurrently with
the Th2 type specific immunity activation and synthesis of
antiviral Abs. After virus injection in the high dose, detectable
amounts of the virus appeared in the CNS on the 1st day of
infection, i.e., before activation of specific immunity. Therefore,
the infectious dose could determine the rate of virus penetration
into the CNS, and, apparently, the severity and character
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of CNS damage caused by cytotoxicity of immunocompetent
cells.
The IFN-α system appears to play a key role in activation of
the innate immunity. It affects activation of immunocompetent
cells and induction of other pro-inflammatory cytokines (Haller
et al., 2006). In our experiments the high infectious dose (106
PFU) induced IFN-α synthesis within 5–10 h p.i. At the same
time, the relatively low infectious dose (103 PFU) could cause
death of all animals, but was unable to activate the production
of type I IFN to detectable levels.
Viral infection activates IFN production through TLR3 in
almost all types of cells (Takeda and Akira, 2005). TLR3 recognize
viral dsRNA in the extracellular environment or in the cytoplasm.
Overby et al. (2010) showed that TBEV infection delayed
activation of IRF-3 and induction of IFN. They hypothesized
that the virus rearranged the internal cell membranes to provide
a compartment for its dsRNA that became inaccessible for
recognition. Alternatively, IFN induction during viral infection
is possible through TLR7 and TLR9 in DCs. TLR7 activates in
the presence of ssRNA in the cell endosomes or after DC’ contact
with a virus-infected cell (Takeda and Akira, 2005; Webster et al.,
2016). It is known that plasmacytoid DCs produce 95% of IFN
(Fitzgerald-Bocarsly, 2002). We could assume that in our case,
IFN synthesis was activated via TLR-7 in plasmacytoid DCs.
To verify this hypothesis, we used murine DCs obtained after
stimulation of bone marrow precursors and showed that these
cells could synthesize IFN-α in a dose-dependent manner at the
very first stages of the infection.
Infection with both studied TBEV strains in the low dose was
not accompanied by IFN type I accumulation in mouse blood;
however, infection of DCs with the low dose of the EK-328 strain
led to production of IFN-α within 5 h p.i. This could indicate
that subpopulations of DCs undergo activation differently in
vivo and in vitro or that the probability of DC-virus contact
dramatically decreased at the low infectious dose. The latter is
highly possible, because the amount of DCs in the blood is
less than 1% (Fitzgerald-Bocarsly, 2002). Thus, the type of cells
interacting with the virus during the first stage of infection, and
the coordination of the immune response can depend on the
virus infectious dose.
The characterization of immune response activation after
injection of different viral doses requires further investigation.
At the same time, our data suggest that an infectious dose
can significantly affect the character of the immune response
activation. It is obvious, when doses causing asymptomatic and
acute infections are being compared. We first have shown that
even during lethal infection an infectious dose can play an
important role.
We found that infection caused by administration of 103
PFU of both TBEV strains to mice was characterized by two-
wave viremia. The EK-328 strain demonstrated a significant
increase in virus titers in blood of mice on the first day of
infection. In the Absettarov-infected mice, the second peak of
viremia with high virus titers in brain was significantly more
pronounced than in mice infected with the EK-328 strain.
Moreover, for the Absettarov strain, relatively high titers of
neutralizing Abs coincided with the second peak of viremia,
i.e., we observed a non-sterile immunity. TBE is characterized
by non-sterile immunity when the infectious virus is isolated
from the sera of patients wherein titers of neutralizing Abs
are high (Levkovich et al., 1960). However, the mechanism of
the non-sterile immunity is not well understood. Theoretically,
several explanations can be proposed: the presence of escape
mutants, induction of a high amount of low-avidity Abs, the
difference in switching the synthesis from less specific IgM to
more efficient IgG Abs, and an unknown ability of the virions
to avoid interaction with Abs. Here we have demonstrated that
virulent TBEV strains can differ by their ability to induce non-
sterile immunity.
Both studied TBEV strains induced a surge of cytokine
production during the terminal stage of infection, which could be
considered as a cytokine storm. We could observe a significant
increase in cytokine level in blood of the EK-328-infected mice
only in the terminal stage of infection after injection of the high
dose of the virus; while in the Absettarov-infected mice, the
cytokine storm coincided with the appearance of the first disease
symptoms. The cytokine storm in the CNS of infected mice at
the terminal stage of infection was previously described after IC
inoculation of TBEV (Salichev et al., 2013). In our experiments
the differences between the studied TBEV strains might be
associated with different speed of cytokines levels increase in the
blood or brain as well as with a limited communication between
blood and cerebrospinal fluid.
In the present study, highly virulent TBEV strains differed
by characteristics of their interaction with DCs: level of virus
reproduction, virus dose triggering IFN-α production, and
impact on DCs’ maturation. It is the first description of TBEV
interaction with DCs, and the studied virulent TBEV strains
differed significantly in the impact on DCs’ maturation and Ag
presentation to CD4+ lymphocytes.
Therefore, comparison of two TBEV strains similar by their
virulence rate in mice after peripheral injection in equal viral
dose showed significant variation in the process of infection and
immune response activation:
(1) different dynamics of virus detection in blood of infected
animals (Figure 1); (2) different ability to induce non-sterile
immunity; (3) different dynamics of IFN-α, -γ, TNF-α, and IL-
12 synthesis during the early stages of infection (before 28 h p.i.);
(4) different dynamics of the synthesis of the cytokines at days
1 and 7 p.i.; (5) different dynamics of cytokine storm in blood
of infected animals during the terminal stages of infection; and
(6) different characteristics of virus interaction with DCs: level
of reproduction, influence on DCs’ maturation, and induction of
IFNs.
We cannot associate the identified differences in the strain
characteristics with the virus subtype. TBEV strains of various
subtypes have demonstrated significant differences in their
virulence in animal experiments (Il’enko et al., 1974; Kozlovskaya
et al., 2010; Palus et al., 2013). In order to establish a
correlation between the virus subtype and its pathogenetic and
immunogenetic characteristics, extensive studies with the use of
several strains belonging to different TBEV subtypes are required.
We realize that the present data could only partially be
projected to the features of the TBEV population, which
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circulates in ticks in nature. The strains used in the present study
underwent more than five passages through the mouse brains
and as a result they could increase their virulence in laboratory
animals. Nevertheless, two general conclusions can be made:
(1) the virus dose during the lethal infection determines the
characteristics of the immune response; (2) highly virulent TBEV
strains can differ in the characteristics of their interaction with
the host immune system. In this study we have tried to present
more or less general picture of experimental TBE, defining the
effects of the infectious dose and strain peculiarities. These data
are important for understanding the immune response during
TBE and can be utilized in development or testing of the novel
compounds for TBE prophylaxis or treatment.
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